Quantcast

Breakthrough Vitamin K Compounds May Reverse Alzheimer’s Damage

SciTechDaily – In a groundbreaking study, researchers from the Shibaura Institute of Technology in Japan developed new forms of vitamin K with stronger effects on brain cells.

The team not only enhanced the vitamin’s neuroactive properties but also uncovered a previously unknown mechanism through which it promotes the formation of neurons.

Explaining the findings, Dr. Hirota stated,

“The newly synthesized vitamin K analogues demonstrated approximately threefold greater potency in inducing the differentiation of neural progenitor cells into neurons compared to natural vitamin K.

“Since neuronal loss is a hallmark of neurodegenerative diseases such as Alzheimer’s disease, these analogues may serve as regenerative agents that help replenish lost neurons and restore brain function.”

...article continued below
- Advertisement -

Toward Vitamin K-Based Therapies for Neurodegeneration

Overall, the study sheds light on the mechanism by which vitamin K and its structural analogues exert neuroprotective effects, paving the way for the development of novel therapeutic agents that can delay or reverse neurodegenerative diseases.

Concluding with the long-term implications of their work, Dr. Hirota says,

“Our research offers a potentially groundbreaking approach to treating neurodegenerative diseases.

“A vitamin K-derived drug that slows the progression of Alzheimer’s disease or improves its symptoms could not only improve the quality of life for patients and their families but also significantly reduce the growing societal burden of healthcare expenditures and long-term caregiving.”

We hope their research translates into clinically meaningful treatments for patients battling neurological diseases.

Reference: “A New Class of Vitamin K Analogues Containing the Side Chain of Retinoic Acid Have Enhanced Activity for Inducing Neuronal Differentiation” by Yoshihisa Hirota, Taiki Sato, Rina Watanabe, Kazuki Takeda, Sho Sano, Satoshi Asano, Yuki Shibahashi, Yumi Yasuda, Yuta Takagi, Yutaro Yamashita, Wu YuXin, Mikino Arakawa, Yuri Maitani, Vannessa Lawai, Kurumi Nakagawa, Natsuko Furukawa, Atsuko Takeuchi, Chisato Tode, Maya Kamao, Akimori Wada, Zainab Ngaini and Yoshitomo Suhara, 3 July 2025, ACS Chemical Neuroscience.
DOI: 10.1021/acschemneuro.5c00111
- Advertisement -
- Advertisement -
- Advertisement -

TRENDING

- Advertisement -
- Advertisement -